firstly - I am very interested in the NW USA manufacturing plant - if anyone can elaborate on that.. would be much appreciated!!
OK - I had to do it.. was going to leave it and go to bed.. but I just had to!
I said I'd re-do my calcs after the meeting anyway.. I will use 'real/conservative' figures in this calc.
And 65% gross margin =) gotta be happy with that! We were assuming 35% gross margin before !
OK here she comes:
40,000 courses sold by FY09
US$650 per course
250m shares
PE of 20
40,000 x 650 = $26m net profit before tax
26m / 250m shares = 10.4c x 15 = $2.08 per share from Ropren sales ALONE.
BIO A sales to have a substantial impact on the bottom line also.
PE of 20? I would dare say by this time next year we'll have a higher PE.. but we'll stick to this for conservatism sake.
Gosh. Please dont say I'm a ramper. These sales are GOING TO HAPPEN !! Scutinise as much as you like =) While BioA sales are happening in the background =) =) alright time to hit the sack!
- Forums
- ASX - By Stock
- SLA
- what is she worth
what is she worth
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online